Hals PA - Search Results

1

In vivo stability and excretion of gadodiamide (GdDTPA-BMA), a hydrophilic gadolinium complex used as a contrast enhancing agent for magnetic resonance imaging.

Normann PT, Hals PA. Normann PT, et al. Among authors: hals pa. Eur J Drug Metab Pharmacokinet. 1995 Oct-Dec;20(4):307-13. doi: 10.1007/BF03190250. Eur J Drug Metab Pharmacokinet. 1995. PMID: 8983938

2

A respiration-metabolism chamber system and a GC-MS method developed for studying exhalation of perfluorobutane in rats after intravenous injection of the ultrasound contrast agent Sonazoid.

Uran S, Landmark K, Normann PT, Hals PA, Toft KG, Skotland T. Uran S, et al. Among authors: hals pa. J Pharm Biomed Anal. 2005 Sep 15;39(3-4):746-51. doi: 10.1016/j.jpba.2005.04.038. J Pharm Biomed Anal. 2005. PMID: 15964732

3

Disposition of perfluorobutane in rats after intravenous injection of Sonazoid.

Toft KG, Hustvedt SO, Hals PA, Oulie I, Uran S, Landmark K, Normann PT, Skotland T. Toft KG, et al. Among authors: hals pa. Ultrasound Med Biol. 2006 Jan;32(1):107-14. doi: 10.1016/j.ultrasmedbio.2005.09.008. Ultrasound Med Biol. 2006. PMID: 16364802

4

In vivo cleavage rate of a dextran-bound magnetic resonance imaging contrast agent: preparation and intravascular pharmacokinetic characteristics in the rabbit.

Hals PA, Sontum PC, Holtz E, Klaveness J, Rongved P. Hals PA, et al. Curr Drug Deliv. 2013 Feb;10(1):134-43. doi: 10.2174/1567201811310010019. Curr Drug Deliv. 2013. PMID: 22452401

5

Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.

Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H. Harpur ES, et al. Among authors: hals pa. Invest Radiol. 1993 Mar;28 Suppl 1:S28-43. doi: 10.1097/00004424-199303001-00004. Invest Radiol. 1993. PMID: 8486501 Review.

6

Metabolism of levomepromazine in man.

Hals PA, Dahl SG. Hals PA, et al. Eur J Drug Metab Pharmacokinet. 1995 Jan-Mar;20(1):61-71. doi: 10.1007/BF03192290. Eur J Drug Metab Pharmacokinet. 1995. PMID: 7588996

7

Human pharmacokinetics of iodixanol.

Svaland MG, Haider T, Langseth-Manrique K, Andrew E, Hals PA. Svaland MG, et al. Among authors: hals pa. Invest Radiol. 1992 Feb;27(2):130-3. doi: 10.1097/00004424-199202000-00007. Invest Radiol. 1992. PMID: 1601604

8

Biodistribution and toxicity of MR imaging contrast media.

Oksendal AN, Hals PA. Oksendal AN, et al. Among authors: hals pa. J Magn Reson Imaging. 1993 Jan-Feb;3(1):157-65. doi: 10.1002/jmri.1880030128. J Magn Reson Imaging. 1993. PMID: 8428083 Review. No abstract available.

9

High-performance liquid chromatographic determination of levomepromazine (methotrimeprazine) and its main metabolites in serum and urine.

Loennechen T, Andersen A, Hals PA, Dahl SG. Loennechen T, et al. Among authors: hals pa. Ther Drug Monit. 1990 Nov;12(6):574-81. doi: 10.1097/00007691-199011000-00011. Ther Drug Monit. 1990. PMID: 2275005

10

Effect of levomepromazine and metabolites on debrisoquine hydroxylation in the rat.

Hals PA, Dahl SG. Hals PA, et al. Pharmacol Toxicol. 1994 Nov;75(5):255-60. doi: 10.1111/j.1600-0773.1994.tb00357.x. Pharmacol Toxicol. 1994. PMID: 7870695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters